XTLB (XTLB) Stock Price & Analysis
XTLB (XTLB) rose 4.04% to USD 2.32 as of June 10, 2026 at 05:21 UTC, according to Nexqual real-time market data.
XTLB last closed at USD 2.23; the session ranged USD 2.07–2.38 on volume of 23,219 shares. Market capitalization is $5.49M, with a 52-week range of USD 2.02–10.28 (NCM). Source: Nexqual, June 10, 2026 at 05:21 UTC.
Key Statistics (as of June 10, 2026 at 05:21 UTC)
| Price | USD 2.32 |
|---|---|
| Change | ▲ 4.04% (up) |
| Previous Close | USD 2.23 |
| Open | USD 2.24 |
| Day Range | USD 2.07 – 2.38 |
| 52-Week Range | USD 2.02 – 10.28 |
| Volume | 23,219 shares |
| Market Cap | $5.49M |
| Exchange | NCM |
Technical Analysis (XTLB)
Nexqual's technical model rates XTLB "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.62 (neutral) |
| vs SMA50 | Below (USD 2.6) |
| MACD | -0.15 (negative) |
Analyst Ratings (XTLB)
Wall Street analysts rate XTLB "None", per Nexqual as of June 10, 2026 at 05:21 UTC.
| Consensus Rating | None |
|---|
Earnings (XTLB)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2016-03-31 | USD -0.04 vs est 0 ▼ miss |
| 2015-12-31 | USD -0.06 vs est 0 ▼ miss |
| 2015-09-30 | USD -0.02 vs est -0.2 ▲ beat |
| 2015-06-30 | USD -0.02 vs est 0 ▼ miss |
Source: Nexqual, June 10, 2026 at 05:21 UTC.
Financials & Fundamentals (XTLB)
| Total Revenue | $968,000 |
|---|---|
| Gross Margin | -232.85% |
| Operating Margin | -853.58% |
| Profit Margin | +0.00% |
| ROE | -577.13% |
| Current Ratio | 0.7 |
| Total Cash | $259,000 |
| Total Debt | $86,000 |
Source: Nexqual, June 10, 2026 at 05:21 UTC.
Financial Health Score (XTLB)
Nexqual rates XTLB's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:21 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $259K cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -577%, ROA -240.6% |
Ownership (XTLB)
| Insider Ownership | +38.46% |
|---|---|
| Institutional Ownership | +3.17% |
| Shares Outstanding | 2.37M |
| Float | 686,401 |
| Short % of Float | +3.98% |
Source: Nexqual, June 10, 2026 at 05:21 UTC.
Leadership (XTLB)
XTLB is led by Noam Band (age 55), CEO & Director, per Nexqual as of June 10, 2026 at 05:21 UTC.
| CEO & Director | Noam Band (age 55) |
|---|---|
| Chief Financial Officer | Segal Niv |
Major Backers & Investors (XTLB)
Notable institutional backers of XTLB include Noked Israel Ltd., Smartharvest Portfolios, LLC, Rhumbline Advisers, according to Nexqual as of June 10, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Noked Israel Ltd. | 2.1% |
| Smartharvest Portfolios, LLC | 0.56% |
| Rhumbline Advisers | 0.25% |
| Gamma Investing LLC | 0.14% |
Source: Nexqual, June 10, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | USD 10.81 | ▲ 2.46% |
| XBIO | Xenetic Biosciences, Inc. | USD 3.08 | ▼ 0.23% |
| KZIA | Kazia Therapeutics Limited | USD 11.42 | ▲ 3.91% |
| TENX | Tenax Therapeutics, Inc. | USD 10.73 | ▲ 0% |
| ZCMD | Zhongchao Inc. | USD 0.78 | ▼ 2.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:21 UTC. This page is informational and not investment advice.